Cargando…

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome

BACKGROUND: Epigenetic alterations may provide valuable insights into gene–environment interactions in the pathogenesis of inflammatory bowel disease [IBD]. METHODS: Genome-wide methylation was measured from peripheral blood using the Illumina 450k platform in a case-control study in an inception co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalla, Rahul, Adams, Alex T, Nowak, Jan K, Bergemalm, Daniel, Vatn, Simen, Ventham, Nicholas T, Kennedy, Nicholas A, Ricanek, Petr, Lindstrom, Jonas, Söderholm, Johan, Pierik, Marie, D’Amato, Mauro, Gomollón, Fernando, Olbjørn, Christine, Richmond, Rebecca, Relton, Caroline, Jahnsen, Jørgen, Vatn, Morten H, Halfvarson, Jonas, Satsangi, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024547/ https://www.ncbi.nlm.nih.gov/pubmed/36029471 http://dx.doi.org/10.1093/ecco-jcc/jjac127

Ejemplares similares

Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
por: Nowak, Jan K, et al.
Publicado: (2022)

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
por: Vatn, Simen Svendsen, et al.
Publicado: (2022)

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome
por: Olbjørn, Christine, et al.
Publicado: (2019)

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
por: Nowak, Jan Krzysztof, et al.
Publicado: (2020)

The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients
por: Moen, Aina E. Fossum, et al.
Publicado: (2018)

Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy
por: Moen, Aina E. F., et al.
Publicado: (2016)

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017)

The history of genetics in inflammatory bowel disease
por: Ek, Weronica E., et al.
Publicado: (2014)

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013)

Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients
por: Thorkildsen, Lill Therese, et al.
Publicado: (2013)

Age-Dependent Fecal Bacterial Correlation to Inflammatory Bowel Disease for Newly Diagnosed Untreated Children
por: Nwosu, Felix Chinweije, et al.
Publicado: (2013)

Prognostic Biosignatures at Ileocecal Resection: Hope or Reality?
por: Salomon, Benita, et al.
Publicado: (2021)

Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature
por: Olbjørn, Christine, et al.
Publicado: (2020)

Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease
por: Ricanek, Petr, et al.
Publicado: (2015)

Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn’s disease
por: Ricanek, Petr, et al.
Publicado: (2012)

Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
por: Thunberg, Joel, et al.
Publicado: (2022)

Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
por: Trbojević Akmačić, Irena, et al.
Publicado: (2015)

Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)
por: Ventham, Nicholas T., et al.
Publicado: (2023)

Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD
por: Bergemalm, Daniel, et al.
Publicado: (2017)

Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact
por: Detlie, Trond Espen, et al.
Publicado: (2021)

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
por: Ventham, N. T., et al.
Publicado: (2016)

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
por: Kim, HoUng, et al.
Publicado: (2020)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Correction: Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
por: Ventham, Nicholas T., et al.
Publicado: (2015)

Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
por: Ventham, Nicholas T., et al.
Publicado: (2015)

Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease
por: Juzenas, Simonas, et al.
Publicado: (2022)

Inflammatory bowel disease registries for collection of patient iron parameters in Europe
por: Halfvarson, Jonas, et al.
Publicado: (2018)

Transcription and DNA Methylation Patterns of Blood-Derived CD8(+) T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis
por: Gasparetto, Marco, et al.
Publicado: (2021)

Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease
por: Joustra, Vincent, et al.
Publicado: (2022)

Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease
por: Ling Lundström, Maria, et al.
Publicado: (2023)

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
por: Eriksson, Carl, et al.
Publicado: (2023)

Blood Selenium Associated with Health and Fertility in Norwegian Dairy Herds
por: Kommisrud, E, et al.
Publicado: (2005)

Factors Associated with the Persistence of Bullying Victimization From 10th grade to 13th Grade: A Longitudinal Study
por: Lien, Lars, et al.
Publicado: (2013)

Crohn’s Disease Is Associated With Activation of Circulating Innate Lymphoid Cells
por: Mazzurana, Luca, et al.
Publicado: (2020)

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
por: Visuri, Isabella, et al.
Publicado: (2023)

Dynamics of the human gut microbiome in Inflammatory Bowel Disease
por: Halfvarson, Jonas, et al.
Publicado: (2017)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

Norwegian farmers' vigilance in reporting sheep showing scrapie-associated signs
por: Hopp, Petter, et al.
Publicado: (2007)

Risk and Interdependencies in Critical Infrastructures: A Guideline for Analysis
por: Hokstad, Per, et al.
Publicado: (2012)

Physical Fitness in Adolescence and Subsequent Inflammatory Bowel Disease Risk
por: Melinder, Carren, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4fau6qm1mnd7jct38o953bgkbs